Kishore Asha, Sturm Marc, Soman Pillai Kanchana, Hakkaart Christopher, Kalikavil Puthanveedu Divya, Urulangodi Madhusoodanan, Krishnan Syam, Ashok Kumar Sreelatha Ashwin, Rajan Roopa, Pal Pramod Kumar, Yadav Ravi, Sarma Gangadhara, Casadei Nicolas, Gasser Thomas, Bauer Peter, Riess Olaf, Sharma Manu
Comprehensive Care Centre for Movement Disorders, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Kochi, Kerala, India.
Parkinson and Movement Disorder Centre, Centre for Excellence in Neurosciences, Aster Medcity, Kochi, Kerala, India.
NPJ Parkinsons Dis. 2024 Apr 15;10(1):85. doi: 10.1038/s41531-024-00676-4.
The genetic loci implicated in familial Parkinson's disease (PD) have limited generalizability to the Indian PD population. We tested mutations and the frequency of known mutations in the SNCA gene in a PD cohort from India. We selected 298 PD cases and 301 age-matched controls for targeted resequencing (before QC), along with 363 PD genomes of Indian ancestry and 1029 publicly available whole genomes from India as healthy controls (IndiGenomes), to determine the frequency of monogenic SNCA mutations. The raw sequence reads were analyzed using an in-house analysis pipeline, allowing the detection of small variants and structural variants using Manta. The in-depth analysis of the SNCA locus did not identify missense or structural variants, including previously identified SNCA mutations, in the Indian population. The familial forms of SNCA gene variants do not play a major role in the Indian PD population and this warrants further research in the under-represented population.
与家族性帕金森病(PD)相关的基因位点对印度帕金森病患者群体的普遍适用性有限。我们检测了印度帕金森病队列中SNCA基因的突变情况及已知突变的频率。我们选择了298例帕金森病患者和301例年龄匹配的对照进行靶向重测序(质量控制前),同时选取了363例具有印度血统的帕金森病基因组和1029例来自印度的公开可用全基因组作为健康对照(印度基因组计划),以确定单基因SNCA突变的频率。使用内部分析流程对原始序列读数进行分析,通过Manta检测小变异和结构变异。对SNCA基因座的深入分析未在印度人群中发现错义或结构变异,包括先前鉴定出的SNCA突变。SNCA基因变异的家族形式在印度帕金森病患者群体中不发挥主要作用,这值得在代表性不足的人群中进一步研究。